Tumor characteristics, treatments, and oncological outcomes of prostate cancer in men aged ≤50 years: a population-based study.
Raisa S PompeAriane SmithMarco BandiniMichele MarchioniTristan MartelFelix PreisserSami-Ramzi Leyh-BannurahJonas SchiffmannFred SaadHartwig HulandMarkus GraefenShahrokh F ShariatDerya TilkiPierre I KarakiewiczPublished in: Prostate cancer and prostatic diseases (2018)
Young PCa patients have more favorable disease characteristics at presentation, are less frequently treated with RP or BT and more frequently benefit of NLT. PCSM did not differ between young and old patients. However, it is worrisome that recently more young PCa patients are diagnosed at a metastatic stage.